SuperNova Dx, KSB Partner on Inflammatory Marker Test | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – SuperNova Diagnostics today said that it will collaborate with Shenzhen Kang Bao Bio-Technology (KSB) on developing and commercializing diagnostics and services for the measurement of the analyte neopterin.

The firms plan to develop the products and services using SuperNova's AmpCrystal technology and offer them in China and affiliated markets. Financial and further details of the collaboration were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.